{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:03:39Z","timestamp":1793318619413,"version":"4.5.0"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Tumor progression and chronic postsurgical pain (CPSP) in patients with breast cancer are both significantly influenced by inflammation. The associations between immunoinflammatory biomarkers and long-term survival, as well as CPSP, remain ambiguous. This study examined the predictive value of immunoinflammatory biomarkers for both long-term survival and CPSP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data on the clinicopathological characteristics and perioperative peripheral blood immunoinflammatory biomarkers of 80 patients who underwent breast cancer surgery were retrospectively collected. Optimal cut-off values for preoperative immunoinflammatory biomarkers, including the preoperative systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), neutrophil-to-lymphocyte ratio (NLR), and pan-immune-inflammation value (PIV), were established via receiver operating characteristic (ROC) curves. Kaplan\u2212Meier curves and Cox regression analysis were used to evaluate the relationships between preoperative immunoinflammatory biomarkers and long-term survival. The relationships among the perioperative neutrophil count (NEU), monocyte count (MONO), lymphocyte count (LYM), platelet count (PLT), SII, SIRI, NLR, PIV, dynamic changes in peripheral blood cell counts, and CPSP were further assessed using logistic regression analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Kaplan\u2212Meier curves revealed a considerable prolongation of disease-free survival (DFS) and overall survival (OS) in the low preoperative SII, SIRI, NLR, and PIV groups. Multivariate Cox regression analysis revealed that only an elevated preoperative SIRI was an independent risk factor for postoperative DFS (HR=8.890, P=0.038). The incidence of CPSP was 28.75%. Univariate logistic regression analysis revealed that body mass index (BMI), postoperative NEU, MONO, SIRI, and PIV were negatively correlated with the occurrence of CPSP, whereas subsequent multivariate logistic regression analysis revealed that only BMI was independently associated with CPSP (OR=0.262, P=0.023).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Elevated preoperative SIRI was an independent risk factor for poor DFS in breast cancer patients after surgery. In contrast, perioperative immunoinflammatory biomarkers had limited potential for predicting CPSP in patients who underwent breast cancer surgery.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1531639","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T06:45:49Z","timestamp":1738133149000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Peripheral blood immunoinflammatory biomarkers: prospective predictors of postoperative long-term survival and chronic postsurgical pain in breast cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Baoli","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangdi","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolun","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linxin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taihang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peixin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingbing","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiashuo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12358","article-title":"Breast cancer: an up-to-date review and future perspectives","volume":"42","author":"Hong","year":"2022","journal-title":"Cancer Commun (Lond)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.semcancer.2019.08.012","article-title":"Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets","volume":"60","author":"Liang","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70263-3","article-title":"Cancer-related inflammation and treatment effectiveness","volume":"15","author":"Diakos","year":"2014","journal-title":"Lancet Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028662","article-title":"Cancer inflammation and cytokines","volume":"10","author":"Galdiero","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/bjs\/znac319","article-title":"Prognostic role of preoperative circulating systemic inflammatory response markers in primary breast cancer: meta-analysis","volume":"109","author":"Savioli","year":"2022","journal-title":"Br J Surg"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1400893","article-title":"Association of the systemic inflammation and anthropometric measurements with cancer risk: a prospective study in MJ cohort","volume":"14","author":"Bian","year":"2024","journal-title":"Front Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/rapm-2018-000040","article-title":"Risk factors for severe acute pain and persistent pain after surgery for breast cancer: a prospective observational study","volume":"44","author":"Habib","year":"2019","journal-title":"Reg Anesth Pain Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2020.04.088","article-title":"Prevalence and intensity of persistent post-surgical pain following breast cancer surgery: a systematic review and meta-analysis of observational studies","volume":"125","author":"Wang","year":"2020","journal-title":"Br J Anaesth"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000005175","article-title":"Systemic inflammatory response syndrome after surgery: mechanisms and protection","volume":"131","author":"Margraf","year":"2020","journal-title":"Anesth Analg"},{"key":"B13","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1097\/ALN.0000000000002238","article-title":"Persistent postsurgical pain: pathophysiology and preventative pharmacologic considerations","volume":"129","author":"Richeb\u00e9","year":"2018","journal-title":"Anesthesiology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-018-0666-8","article-title":"Chronification of pain: mechanisms, current understanding, and clinical implications","volume":"22","author":"Pak","year":"2018","journal-title":"Curr Pain Headache Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/j.pain.0000000000001413","article-title":"The IASP classification of chronic pain for ICD-11: chronic postsurgical or posttraumatic pain","volume":"160","author":"Schug","year":"2019","journal-title":"Pain"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.5524","article-title":"Comparison of the performance of 6 prognostic signatures for estrogen receptor-positive breast cancer: A secondary analysis of a randomized clinical trial","volume":"4","author":"Sestak","year":"2018","journal-title":"JAMA Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1904819","article-title":"Clinical and genomic risk to guide the use of adjuvant therapy for breast cancer","volume":"380","author":"Sparano","year":"2019","journal-title":"N Engl J Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-021-00781-1","article-title":"A review of prognostic and predictive biomarkers in breast cancer","volume":"23","author":"Tarighati","year":"2023","journal-title":"Clin Exp Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-032221-115501","article-title":"Innate immunity and cancer pathophysiology","volume":"17","author":"Maiorino","year":"2022","journal-title":"Annu Rev Pathol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12929-021-00724-8","article-title":"NLRP3 inflammasome-mediated cytokine production and pyroptosis cell death in breast cancer","volume":"28","author":"Faria","year":"2021","journal-title":"J BioMed Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14060552","article-title":"Exploring inflammatory parameters in lung cancer patients: A retrospective analysis","volume":"14","author":"Feier","year":"2024","journal-title":"J Pers Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12967-023-03924-y","article-title":"Prognostic value of the pretreatment systemic immune-inflammation index in patients with prostate cancer: a systematic review and meta-analysis","volume":"21","author":"Meng","year":"2023","journal-title":"J Transl Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S385328","article-title":"Low pre-chemoradiotherapyPan-immune-inflammation value (PIV) measures predict better survival outcomes in locally advanced pancreatic adenocarcinomas","volume":"15","author":"Topkan","year":"2022","journal-title":"J Inflammation Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1036890","article-title":"Prognostic value of pan-immune-inflammation value in colorectal cancer patients: A systematic review and meta-analysis","volume":"12","author":"Yang","year":"2022","journal-title":"Front Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-0894-7","article-title":"The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials","volume":"123","author":"Fuc\u00e0","year":"2020","journal-title":". Br J Cancer"},{"key":"B27","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1186\/s12935-020-01590-4","article-title":"Prognostic value of systemic immune-inflammation index in patients with urologic cancers: a meta-analysis","volume":"20","author":"Huang","year":"2020","journal-title":"Cancer Cell Int"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1193962","article-title":"Prognostic significance of systemic immune-inflammation index in patients with ovarian cancer: a meta-analysis","volume":"13","author":"Mao","year":"2023","journal-title":"Front Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1275033","article-title":"Preoperative systemic immune-inflammation index as a prognostic indicator for patients with urothelial carcinoma","volume":"14","author":"Zheng","year":"2023","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1492251","article-title":"Prognostic significance of systemic pan-immune-inflammation value in locally advanced cervical cancer","volume":"14","author":"Yan","year":"2024","journal-title":"Front Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis","volume":"106","author":"Templeton","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S69657","article-title":"Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancer","volume":"7","author":"Yao","year":"2014","journal-title":"Onco Targets Ther"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4048\/jbc.2013.16.1.55","article-title":"Usefulness of pretreatment neutrophil to lymphocyte ratio in predicting disease-specific survival in breast cancer patients","volume":"16","author":"Noh","year":"2013","journal-title":"J Breast Cancer"},{"key":"B34","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12935-020-01308-6","article-title":"Prognostic value of the systemic immune-inflammation index in patients with breast cancer: a meta-analysis","volume":"20","author":"Zhang","year":"2020","journal-title":"Cancer Cell Int"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-024-16454-8","article-title":"Prognostic value of the baseline systemic immune-inflammation index in HER2-positive metastatic breast cancer: exploratory analysis of two prospective trials","volume":"32","author":"Pang","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.856064","article-title":"The systemic inflammation response index as an independent predictor of survival in breast cancer patients: A retrospective study","volume":"9","author":"Zhu","year":"2022","journal-title":"Front Mol Biosci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2337729","article-title":"Prognostic and clinicopathological value of systemic inflammation response index (SIRI) in patients with breast cancer: a meta-analysis","volume":"56","author":"Zhang","year":"2024","journal-title":"Ann Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1259929","article-title":"Prognostic significance of the pretreatment pan-immune-inflammation value in cancer patients: an updated meta-analysis of 30 studies","volume":"10","author":"Hai-Jing","year":"2023","journal-title":"Front Nutr"},{"key":"B39","doi-asserted-by":"publisher","first-page":"14662","DOI":"10.1038\/s41598-021-94184-7","article-title":"Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy","volume":"11","author":"\u015eahin","year":"2021","journal-title":"Sci Rep"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1349021","article-title":"Association of immune inflammatory biomarkers with pathological complete response and clinical prognosis in young breast cancer patients undergoing neoadjuvant chemotherapy","volume":"14","author":"Li","year":"2024","journal-title":"Front Oncol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1223786","article-title":"Clinical utility of the pan-immune-inflammation value in breast cancer patients","volume":"13","author":"Qi","year":"2023","journal-title":"Front Oncol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14112675","article-title":"The association between the pan-immune-inflammation value and cancer prognosis: A systematic review and meta-analysis","volume":"14","author":"Guven","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S411592","article-title":"High levels of SII and PIV are the risk factors of axillary lymph node metastases in breast cancer: A retrospective study","volume":"16","author":"Tong","year":"2023","journal-title":"Int J Gen Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"16979","DOI":"10.1038\/s41598-019-53606-3","article-title":"Neutrophil-lymphocyte ratio in metastatic breast cancer is not an independent predictor of survival, but depends on other variables","volume":"9","author":"Ivars Rubio","year":"2019","journal-title":"Sci Rep"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.773078","article-title":"Preoperative systemic inflammatory biomarkers are independent predictors of disease recurrence in ER+ HER2- early breast cancer","volume":"11","author":"Truffi","year":"2021","journal-title":"Front Oncol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25094722","article-title":"Mechanisms and preventative strategies for persistent pain following knee and hip joint replacement surgery: A narrative review","volume":"25","author":"Murphy","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"18(4)","DOI":"10.1016\/j.jpain.2016.11.004","article-title":"The transition of acute postoperative pain to chronic pain: an integrative overview of research on mechanisms","author":"Chapman","year":"2017","journal-title":"J Pain"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3934\/Neuroscience.2024015","article-title":"Neuroinflammation mechanism underlying neuropathic pain: the role of mesenchymal stem cell in neuroglia","volume":"11","author":"Wijayanti","year":"2024","journal-title":"AIMS Neurosci"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2023.2284872","article-title":"Identifying risk factors for chronic postsurgical pain and preventive measures: a comprehensive update","volume":"23","author":"Pergolizzi","year":"2023","journal-title":"Expert Rev Neurother"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aeq323","article-title":"When does acute pain become chronic","author":"Voscopoulos","year":"2010","journal-title":"Br J Anaesth"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1177285","article-title":"Change in perioperative neutrophil-lymphocyte ratio as a potential predictive biomarker for chronic postsurgical pain and quality of life: an ambispective observational cohort study","volume":"14","author":"Shu","year":"2023","journal-title":"Front Immunol"},{"key":"B52","article-title":"High body mass index is a potential risk factor for persistent postoperative pain after breast cancer treatment","volume":"20","author":"van Helmond","year":"2017","journal-title":"Pain Physician"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-024-15682-2","article-title":"Persistent pain after breast cancer treatment, an underreported burden for breast cancer survivors","volume":"31","author":"Strijbos","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.151276","article-title":"Predictors of persistent pain after breast cancer surgery: a systematic review and meta-analysis of observational studies","volume":"188","author":"Wang","year":"2016","journal-title":"CMAJ"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/anae.15958","article-title":"Risk factors for persistent pain after breast cancer surgery: a multicentre prospective cohort study","volume":"78","author":"Tan","year":"2023","journal-title":"Anaesthesia"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/anae.16011","article-title":"Risk factors and prediction modelling for chronic post-surgical pain after breast cancer surgery","volume":"78","author":"Shanthanna","year":"2023","journal-title":"Anaesthesia"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1531639\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T06:45:52Z","timestamp":1738133152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1531639\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":56,"alternative-id":["10.3389\/fimmu.2025.1531639"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1531639","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]},"article-number":"1531639"}}